Globus Medical Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Globus Medical Inc
TickerGMED
CIK #0001237831
CUSIP379577208
SectorLife Sciences
IndustrySurgical & Medical Instruments & Apparatus
Phone6109301800
Address2560 General Armistead Avenue
Audubon, PA 19403
Source [EDGAR]
Market Cap, 13F ($)
Business

Globus Medical, Inc. (together, as applicable, with its consolidated subsidiaries, "Globus," "we," "us" or "our"), headquartered in Audubon, Pennsylvania, is a medical device company that develops and commercializes healthcare solutions whose mission is to improve the quality of life of patients with musculoskeletal disorders. Founded in 2003, Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers and physicians to advance patient care and improve efficiency. Since inception, Globus has listened to the voice of the surgeon to develop practical solutions and products to help surgeons effectively treat patients and improve lives. We have expanded our sales operations across the globe and now serve customers in 51 countries worldwide.

Globus is an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures to address treatment challenges. With over 200 products on the market, we offer a comprehensive portfolio of innovative and differentiated technologies that are used to treat a variety of musculoskeletal conditions of the spine, extremities and pelvis. Although we manage our business globally within one operating segment, we separate our products into two major categories: Musculoskeletal Solutions and Enabling Technologies.

Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures.

CIK Filing 2011 - 2023
[0001237831] 10-K
[0001237831] 10-Q
[0001237831] 3
[0001237831] 4
[0001237831] 5
[0001237831] 8-K
[0001237831] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Kayne Anderson Rudnick Investment Management LLC Globus Medical Inc [2023-02-14] 7.99
Wellington Management Group LLP Globus Medical Inc [2021-02-04] 5.52
Janus Henderson Group PLC Globus Medical Inc [2020-02-14] 7.0
BlackRock Inc Globus Medical Inc [2015-02-03] 5.3
Wellington Management Co LLP Globus Medical Inc [2014-02-14] 8.89
Vanguard Group Inc Globus Medical Inc [2014-02-11] 5.31
Goldman Sachs Asset Management LP Globus Medical Inc [2013-05-10] 6.0
Goldman Sachs Group Inc Globus Medical Inc [2013-02-14] 12.0
[2013-02-13] None
Clarus Lifesciences I LP Globus Medical Inc [2013-02-13] 7.9
Form 3/4/5 Filer 2011 - 2023
Lemaitre Dan
Globus Medical Inc
Zarrilli Stephen T
Tobin James R
Rhoads Ann D
Douglas Robert Andrew
Davidar David D
Huller Kelly
Pfeil Keith W
Scavilla Daniel T
Paul David C
Demski David M
Williams Anthony L
Payne Steven
Liptak Robert
Wheeler Kurt
Schwartz Eric
Murphy A Brett
Baron Richard A
Clarus Ventures I Management, L.P.
Clarus Lifesciences I, L.P.
Galakatos Nicholas
Steinmetz Michael
Henner Dennis
Clarus Ventures I, LLC
Simon Nicholas
Goldman Sachs Investment Partners GP LLC
Goldman Sachs PEP 2004 Advisors LLC
Goldman Sachs Group Inc
GS Direct, L.L.C.
Goldman Sachs Investment Partners Master Fund LP
Goldman Sachs & Co LLC
Goldman Sachs Private Equity Concentrated Healthcare Offshor
Goldman Sachs Private Equity Partners 2004 LP
Goldman Sachs Private Equity Concentrated Healthcare Fund of
Multi-Strategy Holdings Offshore Advisors Inc
Multi-Strategy Holdings LP
Goldman Sachs PEP 2004 Direct Investment Advisors LLC
Goldman Sachs PEP 2004 Employee Funds GP LLC
Goldman Sachs Private Equity Partners 2004 Employee Fund L
GS PEP 2002 Direct Investment Advisors LLC
Goldman Sachs PEP 2004 Offshore Holdings Advisors Inc
Private Equity Partners 2004 Direct Investment Fund LP
Goldman Sachs Private Equity Partners 2004 Offshore Holdings
GS Private Equity Partners 2002 - Direct Investment Fund L
Shares Owned of Total
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 7,174,304.0 7,508,361.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 7,434,076.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 6,689,590.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 2,738,690.0
State Street Corp [2023-03-31] DFND 2,112,374.0 2,284,760.0
William Blair Investment Management LLC [2023-03-31] SOLE 1,510,745.0 1,863,312.0
Nuance Investments LLC [2023-03-31] SOLE 1,846,299.0 1,846,299.0
JPMorgan Chase & Co [2023-03-31] DFND 1,561,017.0 1,836,770.0
Champlain Investment Partners LLC [2023-03-31] SOLE 1,249,475.0 1,645,315.0
Hawk Ridge Capital Management LP [2023-03-31] SOLE 1,595,800.0 1,595,800.0
GW&K Investment Management LLC [2023-03-31] SOLE 1,593,522.0 1,593,522.0
AXA Sa [2023-03-31] DFND 1,505,046.0 1,523,960.0
Marshall Wace LLP [2023-03-31] OTR 0.0 1,522,491.0
Citadel Advisors LLC [2023-03-31] DFND 1,233,865.0 1,233,865.0
Barclays PLC [2023-03-31] SOLE 1,213,115.0 1,213,115.0
Geode Capital Management LLC [2023-03-31] DFND 1,195,942.0 1,209,197.0
Van Berkom & Associates Inc. [2023-03-31] SOLE 691,814.0 1,148,480.0
Bank of New York Mellon Corp [2023-03-31] DFND 952,600.0 1,083,186.0
Geneva Capital Management LLC [2023-03-31] SOLE 900,574.0 922,347.0
Grantham Mayo van Otterloo & Co LLC [2023-03-31] SOLE 798,126.0 892,026.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 210,346.0 839,046.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 795,443.0 809,776.0
Boston Trust Walden Corp [2023-03-31] DFND 562,242.0 680,517.0
Bellevue Group AG [2023-03-31] DFND 647,645.0 647,645.0
Morgan Stanley [2023-03-31] DFND 535,684.0 642,379.0
Paradigm Capital Management Inc/Ny [2023-03-31] SOLE 629,100.0 629,100.0
Qube Research & Technologies Ltd [2023-03-31] SOLE 0.0 605,951.0
Northern Trust Corp [2023-03-31] DFND 23,841.0 558,891.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 550,403.0 550,403.0
Pembroke Management Ltd [2023-03-31] SOLE 546,830.0 546,830.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com